India Ott

India Ott is a Scientist at AstraZeneca since September 2022, contributing to the ADC Biology group within Tumor Targeted Delivery. Previously, India completed three rotations as a Graduate Research Scientist at AstraZeneca, focusing on developing a novel proteomics assay and characterizing the efficacy of clinical stage small molecule inhibitors. Earlier experiences include roles as a Sales Associate at Fenton MacLaren Home Furnishings and research positions at the University of California, Berkeley, where India assisted in examining growth factors and participated in a collaborative bioengineering project. India holds a Bachelor of Science in Bioengineering and Biomedical Engineering from the University of California, Berkeley.